CNS Pharmaceuticals (CNSP) Non-Current Assets (2018 - 2025)
CNS Pharmaceuticals (CNSP) reported Non-Current Assets of $520,665 for Q4 2025, compared with $42,435 a year earlier and up 9.0% from the prior quarter.
Powered by 
Analysis
CNS Pharmaceuticals (CNSP) Non-Current Assets (2018 - 2025) Analysis & Trends
Dating back to Q4 2018, CNS Pharmaceuticals' Non-Current Assets record includes 27 quarters.
- Non-Current Assets has a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $42,435 in FY2024 (-61.3%), $109,683 in FY2023 (-77.5%), $488,470 in FY2022 (-61.8%) and $1.28 million in FY2021 (+258.0%).
- The Q4 2025 figure ranks as the highest quarterly Non-Current Assets since Q3 2022.
- Year over year, Non-Current Assets gained in 1 of the last six quarters, with an average decline of 49.1%.
- The high point for year-over-year Non-Current Assets in five years was Q4 2021 (growth of 258.0%); the low point was Q3 2024 (a decline of 92.0%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $477,523 (Q3 2025), $370,055 (Q2 2025) and $27,289 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | CNS Pharmaceuticals | 2.30 Mn | -39.94 Mn | - | 520,665.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 520,665.00 |
| Sep 30, 2025 | 477,523.00 |
| Jun 30, 2025 | 370,055.00 |
| Mar 31, 2025 | 27,289.00 |
| Dec 31, 2024 | 42,435.00 |
| Sep 30, 2024 | 21,175.00 |
| Jun 30, 2024 | 323,873.00 |
| Mar 31, 2024 | 59,601.00 |
| Dec 31, 2023 | 109,683.00 |
| Sep 30, 2023 | 266,201.00 |
| Jun 30, 2023 | 380,578.00 |
| Mar 31, 2023 | 442,516.00 |
| Dec 31, 2022 | 488,470.00 |
| Sep 30, 2022 | 937,558.00 |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 1.28 Mn |
| Sep 30, 2021 | 351,664.00 |
| Jun 30, 2021 | 355,033.00 |
| Mar 31, 2021 | 358,243.00 |
API Access
CNS Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CNSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CNSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CNSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();